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0001) and ACE genatype (p = 0.018), and the E/AI interacted with age (p < 
0.001). heart rate (p = 0.025) and ACE genotype (p = 0.047). There was a 
strong correlation between FJAp and LVMI in the DD group (r = 0.01, p < 
0.0001) but not in hotorozygotes (r= -0.23, p = 0.25). 
These findings uggest hat the DD gsnotype of the ACE gene is associated 
with impairment of left ventricular diastolic filling in patients with essential 
hypertension. 
~ Blood Pressure Changes i ,  Acute S t roke- -The  
West Birmingham Stroke Pro jec t  
Gregow YH Up, John Zarifts, I Sedaf Farooqi. Michele Beevers, 
Glan Sagar, Gareth Beevers, Universify Department of Medicine, City 
Hospital, Birmingham, England 
To examine blood pressure (BP) changes in stroke and the differences be- 
tween males and females, different ethnic groups and type of stroke (throm- 
bosis, hesmonhage, transient Ischaemic attack), we studied 86 patients (48 
males; mean age 64.2 years -*- e.d.9.2) with acute onset stroke (ictus < 12 
hours) in a district 0anerel hospital. 31 patients (36.0%) had a previous his- 
to~y of hypertension. Manual BPa and BPs recorded using Specalabs 09207 
ambulatory blood pressure monitors (ABPM, n = 73) wore studied. Mean 
BPs (standard eviation (s,d.) in different ethic groups and In different types 
of stroke are as follows: 
(mmHo) ManSBP ManDBP 24hr 24hr dSBP dDBP nSBP nOBP 
SBP OBP 
Whlto 156.3 91.8 141.7 84.2 143.4 85.6 141.9 83.0 
• s.d. 30.1 18.3 21.5 1¢0 20.5 14.4 24.3 16.3 
Back 166.1 86.3 173.4' 91.7 174.7" 92.3 164.2 86.2 
± s.d. 38.4 22.4 30.7 13,5 29,1 13.6 31.6 10.3 
Asian 162.5 88.2 141.1 85.3 141,8 85.4 139.7 84.0 
:E s.d. 24.3 12.5 16.6 10.6 16.5 11.0 18.4 12.6 
Throm. 155.9 88.7 143.7 84.4 144.3 85.1 142.9 82.6 
s.d. 27.5 18.1 21.4 14.0 21.1 14.0 23.0 15.0 
Haem. 172.6 100.0 161.6 91.7 170.5"* 96.0 177.0" 98.0 
=E s.d. 33.5 21.7 39.0 18.0 31.4 14.1 35.2 18.4 
T/AS 154.5 89.8 137.6 85.0 142.2 88.5 131.8 80.5 
:l: s.d. 32.4 14.1 21.2 15.4 21.6 15.4 20.1 15.3 
[SBP - systolic BP, DBP = diastolic 8P; Man.manual; ABPM recordings: d - mean day- 
time, n - mean nighttime, 24 hr - mean 24 hour, TIA - transient ischaemt¢ attack], *p < 
0.001, "*p < 0.05 
The median percentage of successful BP readings by ABPM was 92% 
(IQR 72-98). SBPs as recorded by ABPM were significantly higher in black 
patients with acute stroke and in patients with intracerebral haemonhage, 
who showed a trend towards higher eectumal BPs. There was no difference 
in BPs between males and females and those who were alive or dead 
after 6 months follow.up (p = NS). There was also no difference between 
mean day and night SBP (mean difference = 1.9 rnmHg, p = 0.08) although 
mean daytime DBP was higher than mean nighttime DBP (moan ddference 
24 mmHg, p = 0,01). This study demonstrates higher SBPs as recorded 
by ABPM (but not manually) in black patients with acute stroke in patients 
with intracorebral haemorrhago. ABPM recordings may be useful in the 
assessment of BPs in patients with stroke, who demonstrate a loss of diurnal 
BP rhythm, and may be considered as 'non-dippers'. 
~ Relationship Between Factors Nonhemodynamlc 
and Left Ventrl©ular Hypertrophy In Essential 
Hypertension 
Yongming Hui, ZhongMei Dal, XingGan Chen, ShouHua Jing. E/ectr/c 
Power General Hospital, Beijlng 100073 china 
To assess the effect of nonhemodynamio factors on left ventricular hyper- 
trophy (LVH) 62 essential hypertension (EH) pts (32 men, 30 women, mean 
55 years) and 20 normotenslve health subjects (10 men, 10 women, mean 
52 years) were studied. According to the Devereux formula left venttioular 
mass index (LVMI) was calculated, and EH pts were divided into LVH 0roup 
(LVMI • 125 g/m 2 in men, and > 120 g/m 2 in women) and no LVH group, 
After an overnight fast, blood samples wore taken for the determination of
pemthyrold hormone (PTH), angiotsnsin II (AT II) and aldosterone (ALD) by 
a redlo-immunoassw. Results are presented in the table. 
Parame~ro Control EH LVH no LVH 
(n - 20) (n - 62) (n = 47) (n - 15) 
PTH (pgJml) 25.2:1:7.6 44.1 4-14.8'* 47.1 -t- 15.2"* 33.9±8.4 *# 
AT II (pg/ml) 74.4 :b 38,6 232.7:1:157.3"* 265,3 4-165.'/** 130.1 -I- 68.7 .¢ 
ALP (pg/m|) 83.7~21.1 133.4:1=46.9 °= 144,7 4- 47.'P'* I04.2 :E 24.4 d 
*p .~ 0.005, **p < 0.CO1 vs control group;tp < 0,005 ~'s LVH group, 
AS shown, there was a significant difference in PTH, AT II and ALP between 
EH group and control group, Furthermore, inLVH group PTH, AT I! and AID 
elevated significantly as compared with no LVH group. In addition, we found 
that LVMI correlated with AT II (r = 0.342, p < 0.01) and ALD (r = 0.356, p < 
0,01). There was a mere significant correlation between LVMI and PTH (r = 
0.422, p < 0.0025). 
In conclusion, norhemedynamic factors are important determinants of LV 
mass. Besides the renin-angiotensin-aldosterone system, PTH appears to 
play an important mla in cardiac .hypertrophy. 
~ L e f t  Ventricular Mass and Geometric Dislrihution 
in Treated and Untreated Hypertension: impact by 
Gender 
Migual Zabeigoitia, S. Noor Ur Rahman, Lori Oeaschuk, William E. Haley, 
Steven Yarnws, Cada Yunis, Charles Lucas, William Unn, Usa Kreuse, 
John Amaren¢ The University of Texas Health Science Center, San 
Antonio, "IX 
Several antihypertensive drags can induce left ventzfcular hypertrophy (LVH) 
regression. Thus, LV mass and geometry may be significantly influenced by 
prior Imatment TO define whether left ventricular mass and geom¢~'~ differ 
between treated vs. untreated, ~,,~ con~rof~d vs. uncontrolled (sDBP > 90 
mmHg) hypertension (HTN), 576 pts (men 329, women 247; mean age 61 
yrs) with mild-to-moderste primary HTN and 107 normoteosive (non-HTN) 
subjects (men 63, women 44; mean age 61 yrs) underwent echocardiogra- 
phy. LV mass index (men 134 g/m2, women 110 g/m2) ano geometrical 
daasi~ation (concentric, eccentric, concentric remodeled and normal) wore 
determined by widely accepted methods. LVH was mere prevalent in women 
for beth groups HTN and non-HTN (70% vs. 56%, p < 0.05; 36% vs. 29%, 
p = ns). Among HTN, women but not men, showed differences according 
to previous medication and efficacy. Compared to women controlled, those 
uncontrolled espite medication (58% vs. 80%, p < 0.005), an6 ~ose on no 
medication (58% vs. 68%, p = ns), showed more LVH. Prior treatment had 
no effect on geometry among men, but woman uncontmlk~l had a higher 
prevalence o1 concentric LVH than controlled (6Q% vs. 43%, p < 0.005) or 
on no medication (60% vs. 49%, p < 0.005). In conclusion, women, but not 
men, showed differences in LVH and in geometric distribution according to 
prior treatment and efficacy. Concentric is the predominant form of LVH in 
beth HTN and non-HTN su~ects. 
Sustained-Releese Verspamil Blunts the ,1~. rning 
Hemodynamle Surge Outing Dagy ActivR;: A 
Randomized Trial 
Guido A. Rnslto, Carol McKenno, Ofavio C.E. Gebera, James E. Muller, 
Geoffrey H. Toiler. Institute for Prevention of Cardiovascular Disease, 
De,,-,coness Hospita/, Harvard Meal/ca! Schoof, Boston MA 
It has been hypothesized tha~ the moming stage in blood pressure (BP) and 
heart rate (HR) might cause the Increased morning incidence of myocardial 
infarction by precipit~ng plaque rupture. Since varapamit was found to de- 
crease the incidence of reintarctfon or death in DAVIT ti, we tested whether 
sustained-release vsrapamil (Verelan), given dm'ly at 9 am, blunted the morn- 
ing hermedynamic surge. Twelve subjects with hypertension were studied us- 
ing a randomized, crnss-over, placabo-controlled design. Ambulatory BP and 
HR wore recon~d and the differences loatwaen the means at night (midnight 
to 6 am} and the means during the roaming (6 am to noon) wore calculated. 
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Versl~ ~ e d  morning systolic BP by 12 mml~ (p = O.~t), diastolic 
BP by 11 mmHg (p = 0.001) and HR by 6bpm (p = 0.63) but did not 
significantly reduce BP and HR at night. It therefore lowered the morning 
dso in systolic BP (by 50%, p < 0.001) as shown, diastolic BP ~ 75%, p 
< 0.001) and tended to reduce the HR dse (by 32%, p = 0.175). Sustained- 
release verapamil blunted the morning hemodynamtc surge. This may be a 
mechanism by ~dch varapemil could reduce the risk of plaque d~sruption 
and myocardial infarction in the morning. 
